Orchid Pharma (NSE:ORCHPHARMA) Interest Expense : ₹-164 Mil (TTM As of Mar. 2024)

View and export this data going back to 1997. Start your Free Trial

What is Orchid Pharma Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Orchid Pharma's interest expense for the three months ended in Mar. 2024 was ₹ -35 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2024 was ₹-164 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Orchid Pharma's Operating Income for the three months ended in Mar. 2024 was ₹ 638 Mil. Orchid Pharma's Interest Expense for the three months ended in Mar. 2024 was ₹ -35 Mil. Orchid Pharma's Interest Coverage for the quarter that ended in Mar. 2024 was 18.45. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Orchid Pharma Interest Expense Historical Data

The historical data trend for Orchid Pharma's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orchid Pharma Interest Expense Chart

Orchid Pharma Annual Data

Trend

Mar13

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Interest Expense

Get a 7-Day Free Trial

-41.59

-513.36

-320.12

-322.26

-163.55

Orchid Pharma Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Interest Expense	Get a 7-Day Free Trial															-74.84	-55.45	-38.05	-35.44	-34.61

Orchid Pharma Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹-164 Mil.

Orchid Pharma (NSE:ORCHPHARMA) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Orchid Pharma's Interest Expense for the three months ended in Mar. 2024 was ₹-35 Mil. Its Operating Income for the three months ended in Mar. 2024 was ₹638 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2024 was ₹1,208 Mil.

Orchid Pharma's Interest Coverage for the quarter that ended in Mar. 2024 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Mar. 2024 )	/	Interest Expense (Q: Mar. 2024 )
	=	-1	*	638.39	/	-34.607
	=	18.45

The higher the ratio, the stronger the company's financial strength is.

Orchid Pharma (NSE:ORCHPHARMA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Orchid Pharma Ltd (NSE:ORCHPHARMA) » Definitions » Interest Expense

Traded in Other Exchanges

524372:India

Address

313, Valluvarkottam High Road, Orchid Towers, Nungambakkum, Chennai, TN, IND, 600 034

Website

http://www.orchidpharma.com

Orchid Pharma Ltd is involved in the development, manufacturing, and marketing of diverse bulk actives, formulations, and nutraceuticals. The company operates in one business segment which is Pharmaceutical Products. The company produces various products for cardiovascular, anti-diabetic, neuropsychiatry, veterinary, non-antibiotics, and cephalosporins. The products are grouped under formulations and active pharmaceutical ingredients. The company operates its business throughout the Indian region.

Orchid Pharma (NSE:ORCHPHARMA) Headlines

No Headlines